Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker
2022 · BMC Medicine · 7 citations
https://doi.org/10.1186/s12916-022-02630-8
Tongji Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
7
Citations
1
h-index
0
i10-index
Dongli Kong is an academic researcher from Tongji Hospital. The author has contributed to research in topics: Cervical Cancer and HPV Research & Endometrial and Cervical Cancer Treatments & Urinary Bladder and Prostate Research. The author has an h-index of 1, co-authored 8 publications.
https://doi.org/10.1186/s12916-022-02630-8
https://doi.org/10.6084/m9.figshare.21530096
https://doi.org/10.1016/j.pdpdt.2025.105267
Click to start Chat